Sign In
Buy FIXX
$0.93
+0 (+0%)
At Close: Jun 24, 2024
Homology Medicines Declares Distribution to Common Stockholders
04:30pm, Monday, 18'th Mar 2024
BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of busin
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology M
NEW ORLEANS , Jan. 26, 2024 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
04:08pm, Wednesday, 03'rd Jan 2024
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology M
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders
12:55pm, Thursday, 16'th Nov 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Homology Medicines, Inc. (NASDAQ: FIXX) and Q32 Bio Inc. is fair to Homology shareholde
Q32 Bio and Homology Medicines Announce Merger Agreement
07:05am, Thursday, 16'th Nov 2023
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart (ADX-914) in Phase 2 for the treatment of atopic dermatitis
Homology Medicines Reports Third Quarter 2023 Financial Results
04:33pm, Tuesday, 14'th Nov 2023
- Continuing to Evaluate Strategic Options for the Company and the Pipeline of Genetic Medicines, including HMI-103 -
PHILADELPHIA , Aug. 16, 2023 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) on behalf of the Company's long-te
Best Penny Stocks To Buy? 6 To Watch Before Next Week
11:59am, Friday, 28'th Jul 2023
Penny stocks hold a distinctive charm for many investors. Amidst fluctuating market trends and the occasional downturn, there's often a group of these low-cost stocks surging in value.
Penny Stocks To Buy? 3 To Watch While The Stock Market Is Down
05:34pm, Thursday, 27'th Jul 2023
There's something special about penny stocks. Even when the stock market is down, like it is today, you're likely to find at least a handful exploding higher.
Participant 1 Achieved Clinically Meaningful Reduction in Plasma Phe of Up to 99% Change from Baseline and Below the U.S. PKU Treatment Guideline Threshold (
Homology Medicines (FIXX) Reports Q1 Loss, Lags Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Homology Medicines (FIXX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.20 per share a year ago.
Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates
07:49pm, Thursday, 09'th Mar 2023
Homology Medicines (FIXX) delivered earnings and revenue surprises of -17.65% and 23.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Penny Stocks To Buy According To Analysts, Targets Up To 1,050%
12:02pm, Thursday, 17'th Nov 2022
Analysts say these are penny stocks to buy but do you agree? The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 1,050% appeared first on Penny Stocks to Buy, Picks, News and Informati
